View live charts, options flow & technicals for Waters Corporation →
Open Dashboard
Waters Corporation (WAT) is a healthcare company in the diagnostics & research industry with $4.64B in trailing revenue trading at a 109.8× trailing P/E — analyst consensus: buy.
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Key Statistics
Market Cap
$42.57B
Revenue (TTM)
$4.64B
EPS (TTM)
$3.95
EPS (Fwd est.)
$16.55
Employees
16,000
Trailing P/E
109.76
Forward P/E
26.20
PEG Ratio
1.60
Price / Sales
9.17
Price / Book
2.80
EV / EBITDA
32.73
Beta (5Y)
1.19
Analyst Consensus
Consensus
Buy
Analyst Price Target
+2.6% upside
Target: $444.79
Annual Revenue & Net Income
RevenueNet Income
'22
$2.97B
$710.00M
'23
$2.96B
$640.00M
'24
$2.96B
$640.00M
'25
$3.17B
$640.00M
Earnings History
Quarter
Actual EPS
Estimate
Result
Aug 2026
$3.05
$3.01
Beat (+1.4%)
May 2026
$2.70
$2.31
Beat (+17.0%)
Feb 2026
$4.53
$4.51
Beat (+0.5%)
Nov 2025
$3.40
$3.22
Beat (+5.5%)
Next Earnings Report
Waters Corporation is next expected to report earnings on 30 Oct 2026.
Profitability
56.3%
9.4%
3.6%
Gross MarginOperating MarginNet Margin
Revenue Growth (YoY)
113.4%
Return on Equity
1.9%
Return on Assets
3.6%
Balance Sheet
Cash & Equivalents
$540.00M
Total Debt
$5.48B
Net Position
$4.94B (net debt)
Free Cash Flow (TTM)
$-140.00M
Debt / Equity
36.05
Share Ownership
Institutions 102.3%
Insiders 0.1%
Institutional figure exceeds 100% due to short selling
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures,…
What is WAT's market cap?
Waters Corporation has a market capitalization of approximately $42.57B.
What is WAT's P/E ratio?
Waters Corporation trades at a trailing P/E ratio of 109.8x and a forward P/E of 26.2x, which is above the broad market average of ~25x.
How much revenue does WAT generate?
Waters Corporation generated $4.64B in trailing 12-month revenue.
What do analysts say about WAT?
The analyst consensus rating for Waters Corporation is buy, with a mean price target of $444.79. That implies +2.6% upside from the current price.
When does WAT report earnings?
Waters Corporation is next scheduled to report earnings on 30 Oct 2026.
Does WAT pay a dividend?
Waters Corporation does not currently pay a regular dividend.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Waters Corporation on Apsis Markets.